We are driving innovation with industry and manufacturing partners to transform industries and deliver growth to our economies, thereby helping to improve people’s livelihoods.
We are improving the health of people across the world through new discoveries, treatments and patient pathways and working in partnership to build a transformative health ecosystem in our region.
We are working to understand the impact of climate change on the planet and its people, to improve air quality, and developing new technologies to decarbonise energy and transport in partnership with industry and government.
We are working with our partners to tackle inequalities in all aspects of society, striving to make change for a fairer world and one in which people can enjoy a fulfilling, rewarding life.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.
With more than 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
Cancer Research UK Clinical Trials Unit (CRCTU) has a presence in nearly 400 sites in over 20 countries delivering its vision for innovative and efficient trials to meet the needs of patients in the modern era of multi-modality and multiomic therapeutics.
Our full portfolio of trials.
CRCTU welcomes applications to collaborate with us.
Our new Clinical Trials MSc covers the theoretical and practical aspects of the design, conduct, analysis and interpretation of clinical trials.
29 April 2016
Researchers have found that long-term exposure to environmental pollutants was associated with increased risk of mortality for many types of cancer in an elderly Hong Kong population.
14 April 2016
Two multi-disciplinary teams of scientists from the University of Birmingham have been shortlisted for the final stages of Cancer Research UK's global Grand Challenge – an ambitious series of £20m cancer grants tackling some of the toughest questions in cancer research.
31 March 2016
Head and neck cancer patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells, as research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection.
03 February 2016
Professor Andrew Peet, and his team at the University of Birmingham and Birmingham Children's Hospital are looking to find a way to get more detailed information from MRI scans for children with brain tumours
20 October 2015
Birmingham scientists find evidence of how incurable cancer develops
29 September 2015
Sylvia Jochems, PhD candidate in the Institute of Cancer and Genomic Sciences at the University of Birmingham and Maastricht University discusses the role diet plays in the development and treatment of cancer.
01 September 2015
Researchers at the University of Birmingham have made a breakthrough in understanding how mutated genes in leukaemia reprogram blood stem cells and send them spiralling out of control.
04 August 2015
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body's immune cells, leaving them too physically drained to fight the disease,.
25 March 2015
Scientists have found that genetic changes in bowel tumours are linked to the way the body's immune system responds to the cancer, according to research published today in the journal OncoImmunology.
10 March 2015
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Leukaemia & Lymphoma Research's Trial Acceleration Programme: connecting with the national portfolio through the NCRI Clinical Studies Groups.
27 February 2015
Researchers at the University of Birmingham believe that a simple urine test could help to guide clinicians in the treatment of bladder cancer patients.
View all news